Friedman Paul A insider trades
Friedman Paul A has filed 20 Form 4s with the SEC that we hold, for Madrigal Pharmaceuticals, INC. (MDGL) (Director), Prelude Therapeutics Inc (PRLD) (Director) and ALXN (Director). Across all of them we count 0 purchases worth $0 and 104 sales worth $126.3M reported on Form 4. In the last 12 months: 0 purchases ($0) and 38 sales ($26.7M). The largest single trade was a sale of 28,976 shares of Madrigal Pharmaceuticals, INC. worth $10.8M, dated 2025-08-13. The first filing on our record is dated 2021-07-23 and the latest 2026-06-10.
Madrigal Pharmaceuticals, INC. (MDGL)
Director · 14 filings · 104 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-04-03 | S, sale reported on Form 4 | 1,821 | $448.5K | 2024-04-05 |
| 2024-04-03 | S, sale reported on Form 4 | 18,806 | $4.6M | 2024-04-05 |
| 2024-04-03 | S, sale reported on Form 4 | 4,301 | $1.1M | 2024-04-05 |
| 2024-04-03 | S, sale reported on Form 4 | 2,294 | $558.9K | 2024-04-05 |
| 2024-04-03 | S, sale reported on Form 4 | 185 | $44.8K | 2024-04-05 |
| 2024-04-04 | S, sale reported on Form 4 | 627 | $153.2K | 2024-04-05 |
| 2024-04-04 | S, sale reported on Form 4 | 1,467 | $356.5K | 2024-04-05 |
| 2024-04-04 | S, sale reported on Form 4 | 5,299 | $1.3M | 2024-04-05 |
| 2024-04-04 | S, sale reported on Form 4 | 6,273 | $1.5M | 2024-04-05 |
| 2024-04-04 | S, sale reported on Form 4 | 200 | $49.7K | 2024-04-05 |
| 2024-04-04 | S, sale reported on Form 4 | 737 | $182.1K | 2024-04-05 |
| 2024-04-04 | S, sale reported on Form 4 | 1,558 | $383.5K | 2024-04-05 |
| 2024-04-04 | S, sale reported on Form 4 | 2,549 | $624.9K | 2024-04-05 |
| 2024-04-05 | S, sale reported on Form 4 | 1,420 | $340.9K | 2024-04-05 |
| 2024-04-05 | S, sale reported on Form 4 | 444 | $109.2K | 2024-04-05 |
| 2024-04-05 | S, sale reported on Form 4 | 5,228 | $1.3M | 2024-04-05 |
| 2024-04-05 | S, sale reported on Form 4 | 3,966 | $968.6K | 2024-04-05 |
| 2024-04-05 | S, sale reported on Form 4 | 9,264 | $2.3M | 2024-04-05 |
| 2024-04-05 | S, sale reported on Form 4 | 6,679 | $1.6M | 2024-04-05 |
| 2024-04-05 | S, sale reported on Form 4 | 612 | $147.6K | 2024-04-05 |
| 2024-04-08 | S, sale reported on Form 4 | 4,866 | $1.2M | 2024-04-10 |
| 2024-04-08 | S, sale reported on Form 4 | 3,464 | $858.2K | 2024-04-10 |
| 2024-04-08 | S, sale reported on Form 4 | 5,028 | $1.2M | 2024-04-10 |
| 2024-04-08 | S, sale reported on Form 4 | 2,078 | $510.6K | 2024-04-10 |
| 2024-04-08 | S, sale reported on Form 4 | 5,663 | $1.4M | 2024-04-10 |
| 2024-04-08 | S, sale reported on Form 4 | 3,730 | $910.6K | 2024-04-10 |
| 2024-04-08 | S, sale reported on Form 4 | 1,441 | $350.1K | 2024-04-10 |
| 2025-07-16 | S, sale reported on Form 4 | 5,541 | $1.9M | 2025-07-18 |
| 2025-07-16 | S, sale reported on Form 4 | 2,371 | $833.1K | 2025-07-18 |
| 2025-07-16 | S, sale reported on Form 4 | 2,110 | $744.1K | 2025-07-18 |
| 2025-07-16 | S, sale reported on Form 4 | 2,319 | $820.5K | 2025-07-18 |
| 2025-07-16 | S, sale reported on Form 4 | 6,851 | $2.4M | 2025-07-18 |
| 2025-07-16 | S, sale reported on Form 4 | 5,784 | $2.1M | 2025-07-18 |
| 2025-07-16 | S, sale reported on Form 4 | 1,200 | $427.9K | 2025-07-18 |
| 2025-07-17 | S, sale reported on Form 4 | 2,000 | $700.2K | 2025-07-18 |
| 2025-07-17 | S, sale reported on Form 4 | 700 | $246.1K | 2025-07-18 |
| 2025-07-18 | S, sale reported on Form 4 | 1,400 | $490.0K | 2025-07-22 |
| 2025-08-11 | S, sale reported on Form 4 | 2,903 | $1.0M | 2025-08-13 |
| 2025-08-11 | S, sale reported on Form 4 | 300 | $105.3K | 2025-08-13 |
| 2025-08-12 | S, sale reported on Form 4 | 3,303 | $1.2M | 2025-08-13 |
| 2025-08-12 | S, sale reported on Form 4 | 3,202 | $1.1M | 2025-08-13 |
| 2025-08-12 | S, sale reported on Form 4 | 600 | $215.9K | 2025-08-13 |
| 2025-08-12 | S, sale reported on Form 4 | 4,768 | $1.7M | 2025-08-13 |
| 2025-08-12 | S, sale reported on Form 4 | 6,546 | $2.3M | 2025-08-13 |
| 2025-08-12 | S, sale reported on Form 4 | 5,244 | $1.9M | 2025-08-13 |
| 2025-08-12 | S, sale reported on Form 4 | 5,094 | $1.8M | 2025-08-13 |
| 2025-08-12 | S, sale reported on Form 4 | 8,434 | $3.0M | 2025-08-13 |
| 2025-08-12 | S, sale reported on Form 4 | 5,032 | $1.8M | 2025-08-13 |
| 2025-08-12 | S, sale reported on Form 4 | 1,382 | $487.3K | 2025-08-13 |
| 2025-08-13 | S, sale reported on Form 4 | 1,600 | $573.2K | 2025-08-13 |
| 2025-08-13 | S, sale reported on Form 4 | 455 | $163.5K | 2025-08-13 |
| 2025-08-13 | S, sale reported on Form 4 | 3,153 | $1.1M | 2025-08-13 |
| 2025-08-13 | S, sale reported on Form 4 | 1,754 | $633.4K | 2025-08-13 |
| 2025-08-13 | S, sale reported on Form 4 | 1,439 | $521.3K | 2025-08-13 |
| 2025-08-13 | S, sale reported on Form 4 | 2,591 | $940.7K | 2025-08-13 |
| 2025-08-13 | S, sale reported on Form 4 | 3,529 | $1.3M | 2025-08-13 |
| 2025-08-13 | S, sale reported on Form 4 | 1,716 | $626.7K | 2025-08-13 |
| 2025-08-13 | S, sale reported on Form 4 | 3,152 | $1.2M | 2025-08-13 |
| 2025-08-13 | S, sale reported on Form 4 | 7,119 | $2.6M | 2025-08-13 |
| 2025-08-13 | S, sale reported on Form 4 | 6,788 | $2.5M | 2025-08-13 |
| 2025-08-13 | S, sale reported on Form 4 | 7,992 | $3.0M | 2025-08-13 |
| 2025-08-13 | S, sale reported on Form 4 | 7,877 | $2.9M | 2025-08-13 |
| 2025-08-13 | S, sale reported on Form 4 | 22,710 | $8.4M | 2025-08-13 |
| 2025-08-13 | S, sale reported on Form 4 | 28,976 | $10.8M | 2025-08-13 |
| 2025-08-13 | S, sale reported on Form 4 | 24,166 | $9.0M | 2025-08-13 |
| 2025-08-13 | S, sale reported on Form 4 | 4,155 | $1.6M | 2025-08-13 |
| 2025-12-10 | S, sale reported on Form 4 | 160 | $88.9K | 2025-12-12 |
| 2025-12-10 | S, sale reported on Form 4 | 1,029 | $571.1K | 2025-12-12 |
| 2025-12-10 | S, sale reported on Form 4 | 5,001 | $2.8M | 2025-12-12 |
| 2025-12-10 | S, sale reported on Form 4 | 5,533 | $3.1M | 2025-12-12 |
| 2025-12-10 | S, sale reported on Form 4 | 624 | $341.8K | 2025-12-12 |
| 2025-12-10 | S, sale reported on Form 4 | 535 | $293.5K | 2025-12-12 |
| 2025-12-10 | S, sale reported on Form 4 | 409 | $224.9K | 2025-12-12 |
| 2025-12-10 | S, sale reported on Form 4 | 4,316 | $2.4M | 2025-12-12 |
| 2025-12-10 | S, sale reported on Form 4 | 7,193 | $4.0M | 2025-12-12 |
| 2026-01-09 | S, sale reported on Form 4 | 280 | $154.3K | 2026-01-13 |
| 2026-01-09 | S, sale reported on Form 4 | 2,450 | $1.3M | 2026-01-13 |
| 2026-01-09 | S, sale reported on Form 4 | 681 | $354.8K | 2026-01-13 |
| 2026-01-09 | S, sale reported on Form 4 | 840 | $438.5K | 2026-01-13 |
| 2026-01-09 | S, sale reported on Form 4 | 970 | $507.3K | 2026-01-13 |
| 2026-01-09 | S, sale reported on Form 4 | 1,199 | $628.4K | 2026-01-13 |
| 2026-01-09 | S, sale reported on Form 4 | 2,432 | $1.3M | 2026-01-13 |
| 2026-01-09 | S, sale reported on Form 4 | 1,066 | $560.7K | 2026-01-13 |
| 2026-01-09 | S, sale reported on Form 4 | 1,560 | $822.1K | 2026-01-13 |
| 2026-01-09 | S, sale reported on Form 4 | 575 | $303.7K | 2026-01-13 |
| 2026-01-09 | S, sale reported on Form 4 | 691 | $365.7K | 2026-01-13 |
| 2026-01-09 | S, sale reported on Form 4 | 166 | $87.9K | 2026-01-13 |
| 2026-01-09 | S, sale reported on Form 4 | 280 | $148.6K | 2026-01-13 |
| 2026-01-09 | S, sale reported on Form 4 | 80 | $42.6K | 2026-01-13 |
| 2026-01-09 | S, sale reported on Form 4 | 332 | $177.3K | 2026-01-13 |
| 2026-01-09 | S, sale reported on Form 4 | 148 | $79.2K | 2026-01-13 |
| 2026-01-09 | S, sale reported on Form 4 | 473 | $253.5K | 2026-01-13 |
| 2026-01-09 | S, sale reported on Form 4 | 487 | $261.5K | 2026-01-13 |
| 2026-01-09 | S, sale reported on Form 4 | 80 | $43.0K | 2026-01-13 |
| 2026-01-09 | S, sale reported on Form 4 | 480 | $258.8K | 2026-01-13 |
| 2026-01-09 | S, sale reported on Form 4 | 600 | $324.2K | 2026-01-13 |
| 2026-01-09 | S, sale reported on Form 4 | 40 | $21.8K | 2026-01-13 |
| 2026-01-09 | S, sale reported on Form 4 | 1,480 | $757.7K | 2026-01-13 |
| 2026-01-09 | S, sale reported on Form 4 | 1,094 | $561.3K | 2026-01-13 |
| 2026-01-09 | S, sale reported on Form 4 | 1,345 | $692.2K | 2026-01-13 |
Newest 100 of 104
Prelude Therapeutics Inc (PRLD)
Director · 5 filings · 0 purchases and sales
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
ALXN
Director · 1 filing · 0 purchases and sales
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Source
Counted from the Form 4 filings this reporting owner (SEC CIK 1236927) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms